Sign in

CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company

Foghorn Therapeutics Inc.

Sign in to watch
Ticker
FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-586-3100
Business address
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
  1. 4 Option exercise Chief Financial Officer acquired 26,892 shares (option exercise)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Regulation FD disclosure
  11. 8-K Event Shareholder vote results
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Material agreement · Regulation FD disclosure
  14. DEF 14A Proxy Proxy Statement
  15. 8-K Event Regulation FD disclosure
  16. 10-Q Report Quarterly Report
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 10-K/A Report 10-K/A
  20. 8-K Event Executive or director change

Page 15 of 18 · 356 filings